Symbols / VEEV Stock $188.66 +8.21% Veeva Systems Inc.

Healthcare • Health Information Services • United States • NYQ
VEEV (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. Peter P. Gassner
Exch · Country NYQ · United States
Market Cap 30.79B
Enterprise Value 24.35B
Income 908.91M
Sales 3.20B
FCF (ttm) 1.05B
Book/sh 44.05
Cash/sh 40.17
Employees 7,928
Insider 10d —
IPO Oct 16, 2013
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 34.74
Forward P/E 19.09
PEG 0.80
P/S 9.64
P/B 4.28
P/C —
EV/EBITDA 24.72
EV/Sales 7.62
Quick Ratio 4.81
Current Ratio 4.88
Debt/Eq 1.33
LT Debt/Eq —
EPS (ttm) 5.43
EPS next Y 9.88
EPS Growth 23.20%
Revenue Growth 16.00%
EPS Gr Q/Q 24.80%
Rev Gr Q/Q —
Earnings (next) 2026-06-03
Earnings (prior) 2026-03-04
ROA 7.25%
ROE 13.93%
ROIC —
Gross Margin 75.53%
Oper. Margin 29.41%
Profit Margin 28.44%
Shs Outstand 163.20M
Shs Float 149.84M
Insider Own 8.54%
Instit Own 88.71%
Short Float 6.94%
Short Ratio 2.56
Short Interest 10.36M
52W High 310.50
vs 52W High -39.24%
52W Low 148.05
vs 52W Low 27.43%
Beta 0.92
Impl. Vol. 0.39%
Rel Volume 1.90
Avg Volume 2.97M
Volume 5.63M
Target (mean) $262.68
Tgt Median $266.00
Tgt Low $176.00
Tgt High $350.00
# Analysts 28
Recom Buy
Prev Close $174.34
Price $188.66
Change 8.21%
About

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$262.68
Mean price target
2. Current target
$188.66
Latest analyst target
3. DCF / Fair value
$115.60
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$188.66
Low
$176.00
High
$350.00
Mean
$262.68

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-18 main Oppenheimer Outperform → Outperform $225
2026-04-10 down Citigroup Buy → Neutral $176
2026-03-09 main Citigroup Buy → Buy $291
2026-03-05 main Canaccord Genuity Hold → Hold $235
2026-03-05 main TD Cowen Buy → Buy $300
2026-03-05 main Wells Fargo Overweight → Overweight $317
2026-03-05 main Stifel Buy → Buy $245
2026-03-05 reit Truist Securities Buy → Buy $262
2026-03-05 main RBC Capital Outperform → Outperform $275
2026-03-05 main UBS Neutral → Neutral $220
2026-03-05 main Evercore ISI Group In-Line → In-Line $240
2026-03-05 main Morgan Stanley Equal-Weight → Equal-Weight $215
2026-03-05 main Needham Buy → Buy $270
2026-03-05 main Piper Sandler Overweight → Overweight $285
2026-02-26 main Stifel Buy → Buy $212
2026-02-25 main Barclays Overweight → Overweight $250
2026-02-24 main Oppenheimer Outperform → Outperform $275
2026-02-20 main JP Morgan Overweight → Overweight $296
2026-02-20 main UBS Neutral → Neutral $200
2026-02-17 up Morgan Stanley Underweight → Equal-Weight $205
News
RSS: Latest VEEV news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-30 HUNG PRISCILLA C Director — 750 $155.64 $116,730
2026-04-10 HUNG PRISCILLA C Director — 750 $153.50 $115,125
2026-04-01 SCHWENGER THOMAS D President — 2,043 — —
2026-04-01 VAN WAGENER BRIAN Chief Financial Officer — 872 — —
2026-04-01 KONDATH VIPIN Officer — 2,603 — —
2026-04-01 FADDIS JONATHAN W General Counsel — 8,726 — —
2026-04-01 ZUPPAS ELENI NITSA A President — 8,998 — —
2026-03-05 SCHWENGER THOMAS D President — 1,000 $200.00 $200,000
2026-02-27 SEKHRI PAUL JAI Director — 253 — —
2026-02-27 CARGES MARK T Director — 271 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2026-01-31 2025-01-31 2024-01-31 2023-01-31
Total Revenue
3,195.31
+16.34%
2,746.62
+16.20%
2,363.67
+9.68%
2,155.06
Operating Revenue
3,195.31
+16.34%
2,746.62
+16.20%
2,363.67
+9.68%
2,155.06
Cost Of Revenue
782.02
+11.78%
699.64
+3.30%
677.29
+11.14%
609.40
Reconciled Cost Of Revenue
782.02
+11.78%
699.64
+3.30%
677.29
+11.14%
609.40
Gross Profit
2,413.29
+17.90%
2,046.98
+21.38%
1,686.38
+9.10%
1,545.65
Operating Expense
1,496.92
+10.43%
1,355.55
+7.84%
1,257.05
+15.69%
1,086.56
Research And Development
767.39
+10.72%
693.08
+10.18%
629.03
+20.90%
520.28
Selling General And Administration
729.54
+10.12%
662.47
+5.49%
628.02
+10.90%
566.29
Selling And Marketing Expense
428.80
+8.08%
396.73
+4.00%
381.47
+9.40%
348.69
General And Administrative Expense
300.74
+13.17%
265.74
+7.79%
246.54
+13.30%
217.59
Other Gand A
300.74
+13.17%
265.74
+7.79%
246.54
+13.30%
217.59
Total Expenses
2,278.94
+10.89%
2,055.18
+6.25%
1,934.34
+14.06%
1,695.97
Operating Income
916.37
+32.53%
691.43
+61.05%
429.33
-6.48%
459.09
Total Operating Income As Reported
916.37
+32.53%
691.43
+61.05%
429.33
-6.48%
459.09
EBITDA
954.34
+30.59%
730.82
+58.20%
461.96
-5.38%
488.21
Normalized EBITDA
944.36
+32.73%
711.47
+62.80%
437.02
-9.83%
484.64
Reconciled Depreciation
37.97
-3.58%
39.38
+20.70%
32.63
+12.04%
29.12
EBIT
916.37
+32.53%
691.43
+61.05%
429.33
-6.48%
459.09
Total Unusual Items
9.99
-48.39%
19.35
-22.42%
24.94
+598.04%
3.57
Total Unusual Items Excluding Goodwill
9.99
-48.39%
19.35
-22.42%
24.94
+598.04%
3.57
Net Income
908.91
+27.27%
714.14
+35.84%
525.71
+7.79%
487.71
Pretax Income
1,194.51
+29.93%
919.38
+56.35%
588.02
+15.50%
509.10
Net Non Operating Interest Income Expense
267.22
+28.48%
207.99
+55.51%
133.75
+191.64%
45.86
Net Interest Income
267.22
+28.48%
207.99
+55.51%
133.75
+191.64%
45.86
Interest Income Non Operating
267.22
+28.48%
207.99
+55.51%
133.75
+191.64%
45.86
Interest Income
267.22
+28.48%
207.99
+55.51%
133.75
+191.64%
45.86
Other Income Expense
10.92
-45.29%
19.96
-19.98%
24.94
+501.71%
4.14
Other Non Operating Income Expenses
0.93
+52.86%
0.61
—
0.57
Gain On Sale Of Security
9.99
-48.39%
19.35
-22.42%
24.94
+598.04%
3.57
Tax Provision
285.60
+39.15%
205.24
+229.35%
62.32
+191.34%
21.39
Tax Rate For Calcs
0.00
+7.06%
0.00
+110.65%
0.00
+152.23%
0.00
Tax Effect Of Unusual Items
2.39
-44.74%
4.32
+63.41%
2.64
+1660.71%
0.15
Net Income Including Noncontrolling Interests
908.91
+27.27%
714.14
+35.84%
525.71
+7.79%
487.71
Net Income From Continuing Operation Net Minority Interest
908.91
+27.27%
714.14
+35.84%
525.71
+7.79%
487.71
Net Income From Continuing And Discontinued Operation
908.91
+27.27%
714.14
+35.84%
525.71
+7.79%
487.71
Net Income Continuous Operations
908.91
+27.27%
714.14
+35.84%
525.71
+7.79%
487.71
Normalized Income
901.31
+28.92%
699.11
+38.88%
503.41
+3.95%
484.28
Net Income Common Stockholders
908.91
+27.27%
714.14
+35.84%
525.71
+7.79%
487.71
Diluted EPS
5.44
+25.93%
4.32
+34.16%
3.22
+7.33%
3.00
Basic EPS
5.55
+25.85%
4.41
+34.86%
3.27
+4.14%
3.14
Basic Average Shares
163.67
+1.10%
161.88
+0.84%
160.53
+3.31%
155.38
Diluted Average Shares
167.00
+1.07%
165.23
+1.07%
163.49
+0.65%
162.44
Diluted NI Availto Com Stockholders
908.91
+27.27%
714.14
+35.84%
525.71
+7.79%
487.71
Securities Amortization
—
-22.62
+8.84%
-24.82
-732.23%
-2.98
Line Item Trend 2026-01-31 2025-01-31 2024-01-31 2023-01-31
Total Assets
8,979.34
+22.34%
7,339.76
+24.17%
5,910.92
+23.03%
4,804.30
Current Assets
7,997.63
+26.77%
6,308.80
+26.10%
5,003.21
+26.05%
3,969.31
Cash Cash Equivalents And Short Term Investments
6,560.81
+27.39%
5,150.23
+27.87%
4,027.76
+29.82%
3,102.63
Cash And Cash Equivalents
1,421.23
+27.03%
1,118.79
+59.03%
703.49
-20.64%
886.47
Other Short Term Investments
5,139.58
+27.49%
4,031.44
+21.27%
3,324.27
+50.00%
2,216.16
Receivables
1,310.35
+23.95%
1,057.12
+18.97%
888.54
+13.16%
785.23
Accounts Receivable
1,259.74
+23.95%
1,016.36
+19.27%
852.17
+21.21%
703.05
Gross Accounts Receivable
1,259.99
+23.96%
1,016.41
+19.20%
852.69
+21.20%
703.52
Allowance For Doubtful Accounts Receivable
-0.26
-349.12%
-0.06
+89.04%
-0.52
-10.87%
-0.47
Other Receivables
50.61
+24.16%
40.76
+12.09%
36.37
-55.75%
82.17
Prepaid Assets
—
—
—
—
Other Current Assets
126.47
+24.65%
101.46
+16.73%
86.92
+6.71%
81.46
Total Non Current Assets
981.71
-4.78%
1,030.95
+13.58%
907.71
+8.71%
834.98
Net PPE
145.89
+21.80%
119.78
+15.02%
104.13
-0.97%
105.15
Gross PPE
179.61
+18.77%
151.23
+7.34%
140.89
+2.64%
137.27
Accumulated Depreciation
-33.72
-7.21%
-31.45
+14.43%
-36.76
-14.45%
-32.12
Properties
0.00
0.00
0.00
0.00
Land And Improvements
25.43
+0.00%
25.43
+0.00%
25.43
+0.00%
25.43
Buildings And Improvements
96.61
+13.86%
84.85
+27.42%
66.59
-12.75%
76.32
Machinery Furniture Equipment
10.35
+33.23%
7.77
-56.94%
18.05
+11.22%
16.23
Construction In Progress
2.06
-31.18%
2.99
+9551.61%
0.03
-89.74%
0.30
Other Properties
—
—
—
55.34
Leases
45.15
+49.58%
30.19
-1.97%
30.79
+62.19%
18.99
Goodwill And Other Intangible Assets
470.19
-2.92%
484.34
-3.69%
502.89
-3.73%
522.35
Goodwill
439.88
+0.00%
439.88
+0.00%
439.88
+0.00%
439.88
Other Intangible Assets
30.31
-31.82%
44.46
-29.45%
63.02
-23.59%
82.48
Non Current Deferred Assets
303.38
-18.07%
370.30
+43.87%
257.38
+52.73%
168.52
Non Current Deferred Taxes Assets
273.42
-20.50%
343.92
+47.31%
233.46
+70.79%
136.70
Other Non Current Assets
62.26
+10.11%
56.54
+30.57%
43.30
+11.16%
38.95
Total Liabilities Net Minority Interest
1,764.59
+17.06%
1,507.38
+19.06%
1,266.10
+16.36%
1,088.04
Current Liabilities
1,637.06
+17.07%
1,398.40
+18.62%
1,178.88
+17.09%
1,006.80
Payables And Accrued Expenses
90.23
+20.26%
75.03
-25.00%
100.03
-8.56%
109.40
Payables
44.34
+12.34%
39.47
-44.72%
71.40
-9.28%
78.70
Accounts Payable
37.64
+23.64%
30.45
-3.38%
31.51
-24.39%
41.68
Other Payable
—
6.41
-2.26%
6.56
-1.37%
6.65
Current Accrued Expenses
45.88
+29.05%
35.56
+24.18%
28.63
-6.72%
30.70
Pensionand Other Post Retirement Benefit Plans Current
45.86
+16.30%
39.43
+99.58%
19.76
+17.50%
16.81
Total Tax Payable
6.70
-25.78%
9.02
-72.92%
33.32
+9.72%
30.37
Income Tax Payable
6.70
-25.78%
9.02
-23.93%
11.86
+139.83%
4.95
Current Debt And Capital Lease Obligation
12.15
+21.91%
9.97
+6.80%
9.33
-17.44%
11.31
Current Capital Lease Obligation
12.15
+21.91%
9.97
+6.80%
9.33
-17.44%
11.31
Current Deferred Liabilities
1,488.82
+16.86%
1,273.98
+21.36%
1,049.76
+20.76%
869.28
Current Deferred Revenue
1,488.82
+16.86%
1,273.98
+21.36%
1,049.76
+20.76%
869.28
Total Non Current Liabilities Net Minority Interest
127.53
+17.03%
108.98
+24.96%
87.21
+7.35%
81.24
Long Term Debt And Capital Lease Obligation
83.71
+27.20%
65.81
+41.70%
46.44
-6.50%
49.67
Long Term Capital Lease Obligation
83.71
+27.20%
65.81
+41.70%
46.44
-6.50%
49.67
Non Current Deferred Liabilities
0.56
-4.94%
0.59
-71.39%
2.05
+37.53%
1.49
Non Current Deferred Taxes Liabilities
0.56
-4.94%
0.59
-71.39%
2.05
+37.53%
1.49
Other Non Current Liabilities
43.27
+1.61%
42.59
+9.98%
38.72
+28.73%
30.08
Stockholders Equity
7,214.75
+23.70%
5,832.37
+25.57%
4,644.82
+24.99%
3,716.25
Common Stock Equity
7,214.75
+23.70%
5,832.37
+25.57%
4,644.82
+24.99%
3,716.25
Capital Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Common Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Share Issued
163.78
+0.73%
162.58
+0.82%
161.26
+1.91%
158.24
Ordinary Shares Number
163.78
+0.73%
162.58
+0.82%
161.26
+1.91%
158.24
Additional Paid In Capital
2,843.09
+19.15%
2,386.19
+24.61%
1,915.00
+24.95%
1,532.63
Retained Earnings
4,363.50
+26.31%
3,454.59
+26.06%
2,740.46
+23.74%
2,214.75
Gains Losses Not Affecting Retained Earnings
8.16
+196.96%
-8.42
+20.88%
-10.64
+65.83%
-31.13
Other Equity Adjustments
8.16
+196.96%
-8.42
+20.88%
-10.64
+65.83%
-31.13
Total Equity Gross Minority Interest
7,214.75
+23.70%
5,832.37
+25.57%
4,644.82
+24.99%
3,716.25
Total Capitalization
7,214.75
+23.70%
5,832.37
+25.57%
4,644.82
+24.99%
3,716.25
Working Capital
6,360.57
+29.53%
4,910.40
+28.40%
3,824.33
+29.09%
2,962.51
Invested Capital
7,214.75
+23.70%
5,832.37
+25.57%
4,644.82
+24.99%
3,716.25
Total Debt
95.86
+26.50%
75.78
+35.86%
55.77
-8.53%
60.98
Capital Lease Obligations
95.86
+26.50%
75.78
+35.86%
55.77
-8.53%
60.98
Net Tangible Assets
6,744.56
+26.11%
5,348.04
+29.12%
4,141.93
+29.68%
3,193.90
Tangible Book Value
6,744.56
+26.11%
5,348.04
+29.12%
4,141.93
+29.68%
3,193.90
Line Item Trend 2026-01-31 2025-01-31 2024-01-31 2023-01-31
Operating Cash Flow
1,415.22
+29.83%
1,090.05
+19.61%
911.34
+16.77%
780.47
Cash Flow From Continuing Operating Activities
1,415.22
+29.83%
1,090.05
+19.61%
911.34
+16.77%
780.47
Net Income From Continuing Operations
908.91
+27.27%
714.14
+35.84%
525.71
+7.79%
487.71
Depreciation Amortization Depletion
37.97
-3.58%
39.38
+20.70%
32.63
+12.04%
29.12
Depreciation And Amortization
37.97
-3.58%
39.38
+20.70%
32.63
+12.04%
29.12
Other Non Cash Items
32.18
+13.81%
28.28
-6.80%
30.34
-14.59%
35.52
Stock Based Compensation
472.70
+8.08%
437.35
+11.08%
393.73
+11.89%
351.91
Asset Impairment Charge
—
—
0.69
+170.70%
0.26
Deferred Tax
65.09
+157.98%
-112.27
-6.55%
-105.37
+17.36%
-127.50
Deferred Income Tax
65.09
+157.98%
-112.27
-6.55%
-105.37
+17.36%
-127.50
Operating Gains Losses
—
—
-0.22
-122.86%
0.97
Net Foreign Currency Exchange Gain Loss
—
—
-0.22
-122.86%
0.97
Change In Working Capital
-91.94
-1306.54%
7.62
-87.47%
60.82
+728.65%
7.34
Change In Receivables
-254.55
-50.65%
-168.97
-62.47%
-104.00
-14.18%
-91.08
Changes In Account Receivables
-244.70
-48.69%
-164.57
-9.85%
-149.81
-107.56%
-72.18
Change In Prepaid Assets
-33.83
-93.81%
-17.45
-4315.70%
0.41
+100.87%
-47.40
Change In Payables And Accrued Expense
6.74
+208.42%
-6.21
+17.85%
-7.56
-127.12%
27.89
Change In Accrued Expense
2.98
+310.89%
-1.41
+66.72%
-4.25
-145.81%
9.28
Change In Payable
3.75
+178.22%
-4.80
-44.81%
-3.31
-117.80%
18.61
Change In Account Payable
6.08
+410.05%
-1.96
+80.83%
-10.23
-147.74%
21.43
Change In Other Working Capital
193.06
-8.00%
209.84
+17.96%
177.90
+48.67%
119.66
Change In Other Current Liabilities
-3.35
+65.04%
-9.59
-61.89%
-5.92
-243.76%
-1.72
Investing Cash Flow
-1,104.36
-57.73%
-700.14
+34.95%
-1,076.35
-6.81%
-1,007.68
Cash Flow From Continuing Investing Activities
-1,104.36
-57.73%
-700.14
+34.95%
-1,076.35
-6.81%
-1,007.68
Net Investment Purchase And Sale
-1,075.23
-58.21%
-679.62
+35.28%
-1,050.15
-5.63%
-994.17
Purchase Of Investment
-3,133.08
-21.34%
-2,581.97
+4.30%
-2,697.97
-35.11%
-1,996.88
Sale Of Investment
2,057.85
+8.17%
1,902.35
+15.45%
1,647.81
+64.34%
1,002.71
Net Business Purchase And Sale
—
—
0.00
0.00
Purchase Of Business
—
—
0.00
0.00
Net Other Investing Changes
-29.13
-41.97%
-20.52
+21.67%
-26.20
-93.87%
-13.51
Financing Cash Flow
-9.33
-135.74%
26.11
+261.32%
-16.19
+16.45%
-19.38
Cash Flow From Continuing Financing Activities
-9.33
-135.74%
26.11
+261.32%
-16.19
+16.45%
-19.38
Net Issuance Payments Of Debt
—
—
0.00
0.00
Net Long Term Debt Issuance
—
—
0.00
0.00
Net Common Stock Issuance
-169.95
0.00
0.00
—
Common Stock Payments
-169.95
0.00
0.00
—
Repurchase Of Capital Stock
-169.95
0.00
0.00
—
Proceeds From Stock Option Exercised
253.86
+140.54%
105.54
+68.36%
62.69
+43.60%
43.65
Net Other Financing Charges
-93.25
-17.41%
-79.42
-0.69%
-78.88
-25.14%
-63.03
Changes In Cash
301.53
-27.52%
416.03
+329.60%
-181.20
+26.52%
-246.59
Effect Of Exchange Rate Changes
0.92
+152.97%
-1.74
+2.53%
-1.78
+64.30%
-4.99
Beginning Cash Position
1,120.96
+58.63%
706.67
-20.57%
889.65
-22.04%
1,141.22
End Cash Position
1,423.41
+26.98%
1,120.96
+58.63%
706.67
-20.57%
889.65
Free Cash Flow
1,415.22
+29.83%
1,090.05
+19.61%
911.34
+16.77%
780.47
Income Tax Paid Supplemental Data
229.97
-28.59%
322.05
+139.49%
134.47
-19.93%
167.95
Amortization Of Securities
-9.69
+60.34%
-24.44
+7.81%
-26.52
-631.65%
-3.62
Change In Income Tax Payable
-2.33
+18.04%
-2.84
-141.04%
6.92
+345.68%
-2.81
Change In Tax Payable
-2.33
+18.04%
-2.84
-141.04%
6.92
+345.68%
-2.81
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category